Business Context and Reporting Period
Company: Biorestorative Therapies, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 5, 2012
Reporting Period: Single event date (November 5, 2012)
The filing reports a corporate event regarding the trading status of the Company's common stock. The Company is incorporated in Nevada and maintains its principal executive offices in Jupiter, Florida.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This Form 8-K is a current report regarding a specific event and does not contain financial statements or performance metrics.
Material Changes
Trading Status Change: On November 5, 2012, the Company announced that its common stock has begun trading on the OTC Bulletin Board. This represents a material change in the market availability of the Company's securities.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release (Exhibit 99.1) announcing the OTC Bulletin Board listing. The text explicitly states that the information is furnished, not filed, and will not be incorporated by reference into future registration statements unless specifically identified.
Risks and Contingencies: The filing includes a disclaimer stating that the furnishing of information is not intended to constitute a determination or admission that the information is material or complete, nor does it constitute an investment recommendation.
Investor Verification Checklist
- Verify the current trading symbol and volume for Biorestorative Therapies, Inc. on the OTC Bulletin Board.
- Review the full text of the Press Release (Exhibit 99.1) for details on the listing process and any associated conditions.
- Confirm the Company's current financial status through its most recent 10-K or 10-Q filings, as this 8-K contains no financial data.
- Check for any subsequent filings regarding the Company's compliance with OTC Bulletin Board reporting requirements.